drugset / Trial / NCT06583590
Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction
Phase 2/3
Recruiting
32 enrolled
Aswan University Hospital
Aswan University · collabCairo University · collab
NaSingle-groupOpen-labelTreatment
Summary
Study is aiming to evaluate safety, efficacy and durability of intracavernosal injection (ICI) of Botulinum toxin A plus oral tadalafil in controlled diabetic men with refractory Erectile Dysfunction.
Timeline
- Start
- 2024-08-01
- Primary completion
- 2025-08-31
- Completion
- 2025-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 100 iu | Other |
| Subject | Tadalafil | Small molecule | 5 mg | Oral |